Download:
pdf |
pdfNRC FORM 313A (ANP)
U.S. NUCLEAR REGULATORY COMMISSION
(10-2006)
AUTHORIZED NUCLEAR PHARMACIST TRAINING AND
EXPERIENCE AND PRECEPTOR ATTESTATION
[10 CFR 35.55]
Name of Proposed Authorized Nuclear Pharmacist
APPROVED BY OMB: NO. 3150-0120
EXPIRES: MM/DD/YYYY
State or Territory Where Licensed
PART I -- TRAINING AND EXPERIENCE
(Select one of the two methods below)
* Training and Experience, including board certification, must have been obtained within the 7 years preceding
the date of application or the individual must have obtained related continuing education and experience since
the required training and experience was completed. Provide dates, duration, and description of continuing
education and experience related to the nuclear pharmacy uses.
1. Board Certification
a. Provide a copy of the board certification.
b. Skip to and complete Part II Preceptor Attestation.
2. Structured Educational Program for Proposed Authorized Nuclear Pharmacist
a. Classroom and Laboratory Training.
Description of Training
Location of Training
Clock
Hours
Dates of
Training*
Radiation physics and instrumentation
Radiation protection
Mathematics pertaining to the use
and measurement of radioactivity
Chemistry of byproduct material for
medical use
Radiation biology
Total Hours of Training:
NRC FORM 313A (ANP) (10-2006)
PRINTED ON RECYCLED PAPER
PAGE 1
NRC FORM 313A (ANP)
U.S. NUCLEAR REGULATORY COMMISSION
(10-2006)
AUTHORIZED NUCLEAR PHARMACIST TRAINING AND EXPERIENCE
AND PRECEPTOR ATTESTATION (continued)
2. Structured Educational Program for Proposed Authorized Nuclear Pharmacist (continued)
b. Supervised Practical Experience in a Nuclear Pharmacy.
Description of Experience
Location of Experience/License or
Permit Number of Facility
Clock
Hours
Dates of
Experience*
Shipping, receiving, and performing
related radiation surveys
Using and performing checks for
proper operation of instruments used
to determine the activity of dosages,
survey meters, and, if appropriate,
instruments used to measure alphaor beta-emitting radionuclides
Calculating, assaying, and safely
preparing dosages for patients or
human research subjects
Using administrative controls to avoid
medical events in administration of
byproduct material
Using procedures to prevent or
minimize radioactive contamination
and using proper decontamination
procedures
Total Hours of Experience:
Supervising Individual
c. Go to and complete Part II Preceptor Attestation.
PAGE 2
NRC FORM 313A (ANP)
U.S. NUCLEAR REGULATORY COMMISSION
(10-2006)
AUTHORIZED NUCLEAR PHARMACIST TRAINING AND EXPERIENCE
AND PRECEPTOR ATTESTATION (continued)
PART II – PRECEPTOR ATTESTATION
Note:
This part must be completed by the individual's preceptor. The preceptor does not have to be the supervising
individual as long as the preceptor provides, directs, or verifies training and experience required. If more than
one preceptor is necessary to document experience, obtain a separate preceptor statement from each.
First Section
Check one of the following:
Board Certification
has satisfactorily completed the requirements in
I attest that
Name of Proposed Authorized Nuclear Plarmacist
10 CFR 35.55(a)(1), (a)(2), and (a)(3) and has achieved a level of competency sufficient to function
independently as an authorized nuclear pharmacist.
OR
Structured Educational Program
has satisfactorily completed a 700-hour structured
I attest that
Name of Proposed Authorized Nuclear Pharmacist
educational program consisting of both 200 hours of classroom and laboratory training, and practical
experience in nuclear pharmacy, as required by 10 CFR 35.55(b)(1) and has achieved a level of
competency sufficient to function independently as an authorized nuclear pharmacist.
Second Section
Complete the following for preceptor attestation and signature:
I am an Authorized Nuclear Pharmacist for
,
Nuclear Pharmacy or Medical Facility
.
License/Permit Number
Name of Preceptor
Signature
Telephone Number
Date
PAGE 3
File Type | application/pdf |
File Title | c:\temp\ffcxc3.wpf |
Author | cxc7 |
File Modified | 2007-07-24 |
File Created | 2007-07-24 |